These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 13959207)

  • 1. [Study of the hemostatic defect caused by anticoagulants by evaluation of the intensity of the hemorrhage. I. Direct anticoagulants (heparin and synthetic heparinoids)].
    FRANDOLI G
    G Gerontol; 1962 Jul; 10():733-43. PubMed ID: 13959207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the hemostatic defect caused by anticoagulants by evaluation of the intensity of the hemorrhage. II. Indirect anticoagulants].
    FRANDOLI G
    G Gerontol; 1962 Jul; 10():745-54. PubMed ID: 13959209
    [No Abstract]   [Full Text] [Related]  

  • 3. [RESEARCH ON THE MECHANISM OF ACTION OF A NATURAL HEPARINOID. STUDY OF COAGULATION, FIBRINOLYSIS AND OF THE INTENSITY OF HEMORRHAGE].
    TURAZZA G; GIBELLI A; BISIANI M
    Gazz Int Med Chir; 1963 Dec; 67():2515-26. PubMed ID: 14164429
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disorders of hemostasis and blood coagulation in the course of uremia. Role of a heparinoid anticoagulant].
    MORIAU M; MASURE R
    J Urol Nephrol (Paris); 1962; 68():163-9. PubMed ID: 14476046
    [No Abstract]   [Full Text] [Related]  

  • 5. [RESEARCH ON THE FIBRINOLYTIC AND ANTICOAGULANT ACTION OF A SULFURATED DERIVATIVE OF XYLAN (SYNTHETIC HEPARINOID) WITH A LOW-GRADE POLYMERIZATION].
    CIPOLLI PL; GIBELLI A
    Riv Patol Clin; 1963 Aug; 18():395-403. PubMed ID: 14083551
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANTICOAGULANTS. 2. HEPARINS, HAPARINOIDS, RARE EARTHS AND THROMBOLYTICS].
    REPPEL L
    Pharmazie; 1964 Mar; 19():189-96. PubMed ID: 14248782
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory Assessment of Hemostatic and Anticoagulant Therapy.
    Adcock DM; Gosselin RC
    Semin Thromb Hemost; 2017 Apr; 43(3):242-244. PubMed ID: 28346961
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemostatics and anticoagulants].
    Haddad R
    Rev Dent Liban; 1973 Dec; 23(4):31-51. PubMed ID: 4544160
    [No Abstract]   [Full Text] [Related]  

  • 9. AC5 Surgical Hemostat™ as an effective hemostatic agent in an anticoagulated rat liver punch biopsy model.
    Csukas D; Urbanics R; Moritz A; Ellis-Behnke R
    Nanomedicine; 2015 Nov; 11(8):2025-31. PubMed ID: 25597908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ANTICOAGULANT DRUG THERAPY IN MYOCARDIAL INFARCT].
    MATSUOKA S; HOMMA T
    Sogo Rinsho; 1964 Mar; 13():463-71. PubMed ID: 14140834
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract]   [Full Text] [Related]  

  • 12. THE HAEMOSTATIC MECHANISM IN PATIENTS WITH HAEMORRHAGIC DISEASES. A HISTOLOGICAL STUDY OF WOUNDS MADE FOR PRIMARY AND SECONDARY BLEEDING TIME TESTS.
    JORGENSEN L; BORCHGREVINK CF
    Acta Pathol Microbiol Scand; 1964; 60():55-82. PubMed ID: 14114329
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH; Stier WD; Brunswig D
    Arzneimittelforschung; 1969 Nov; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract]   [Full Text] [Related]  

  • 14. THE INTERPRETATION OF HEMOSTATIC TESTS IN UNEXPLAINED BLEEDING.
    QUICK AJ
    Ann N Y Acad Sci; 1964 Jul; 115():252-9. PubMed ID: 14192829
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    Zmuda K; Neofotistos D; Ts'ao CH
    Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparinoid and heparin; an investigation into the anticoagulant effect of the dextran sulphate dexulate.
    ARGE E
    Acta Med Scand; 1956 Nov; 155(6):469-74. PubMed ID: 13372201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemorrhagic diathesis caused by heparinoid type of circulating anticoagulants].
    JIMENEZ CASADO M
    Rev Clin Esp; 1956 Apr; 61(2):107-9. PubMed ID: 13350763
    [No Abstract]   [Full Text] [Related]  

  • 18. [An outline of hemostatic (hemostatics, styptics) or coagulation-active (anticoagulants, inhibitors) substances and procedures].
    SZIRMAI E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1960; 77():95-109. PubMed ID: 13836406
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-like effect in liver disease and liver transplantation.
    Senzolo M; Cholongitas E; Thalheimer U; Riddell A; Agarwal S; Mallett S; Ferronato C; Burroughs AK
    Clin Liver Dis; 2009 Feb; 13(1):43-53. PubMed ID: 19150308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparinoid and heparin; anticoagulant effects of dexulate, a dextran sulfate preparation].
    ARGE E
    Ugeskr Laeger; 1957 Feb; 119(9):248-51. PubMed ID: 13422709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.